Acrivon Therapeutics, Inc.
Pharmaceutical company · Watertown, Massachusetts, United States · Nasdaq: ACRV
Acrivon Therapeutics, Inc. is a pharmaceutical company headquartered in Watertown, Massachusetts, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker ACRV. It has reported private securities offerings to the US SEC, most recently $100 million sold in a notice filed in 2021.
Acrivon Therapeutics at a glance
What does Acrivon Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $100 million sold (2021).
Frequently asked questions about Acrivon Therapeutics
Where is Acrivon Therapeutics headquartered?
Acrivon Therapeutics, Inc. is headquartered in Watertown, Massachusetts, United States.
What does Acrivon Therapeutics do?
Acrivon Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Acrivon Therapeutics a public company?
Yes. Acrivon Therapeutics, Inc. trades on Nasdaq under the ticker ACRV.
When was Acrivon Therapeutics founded?
The earliest incorporation on record for Acrivon Therapeutics, Inc. is in 2018, according to public company registers.
Similar companies
- Camp4 Therapeutics CorpWatertown, Massachusetts, United States
- Tetraphase Pharmaceuticals IncWatertown, Massachusetts, United States
- Disc Medicine, Inc.Watertown, Massachusetts, United States
- Enanta Pharmaceuticals IncWatertown, Massachusetts, United States
- Pandion Therapeutics, Inc.Watertown, Massachusetts, United States
- Nocion Therapeutics, Inc.Watertown, Massachusetts, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences